Cerebras Systems Inc.

The stock is in a post-IPO reset after a sharp drawdown from the 52-week high of 386.34, but it remains well above the 52-week low near 185. The shares are below the 200-day moving average, signaling a damaged intermediate trend that needs base-building before momentum can reassert itself.

Street sentiment is constructive: consensus sits at Buy, and the average target of 297.25 is above the current share price. Recent action has been mostly positive, with multiple firms initiating coverage in early June and several targets raised on June 24, including UBS to 320 and Wedbush to 280.

Next earnings are due 2026-09-22, and estimates point to a loss in 2026 before a return to profitability in 2027. Analysts see 2026 revenue at 831.46 million and EPS at -1.14, so shareholders should watch whether revenue scale and margin discipline track toward that rebound.

No notable discretionary insider buying or selling; the recent activity is dominated by conversion-related filings from directors and 10% owners. That pattern reads as ownership restructuring rather than a fresh signal on near-term operating conviction.

Profitability is mixed but improving at the top line: gross margin is 39.0% and revenue growth is 14.744% year over year. The balance sheet is strong with 1.108 billion in cash and equivalents versus 261.822 million of debt, leaving 846.415 million in net cash.

CBRS stands out as an AI infrastructure semiconductor name with a wafer-scale platform aimed at inference and generative AI workloads, which gives it a differentiated pitch versus conventional chip peers. The valuation is still rich, with a negative trailing P/E and a market cap of 41.4 billion despite limited current earnings.